Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
BioWorld financial watch
| BioWorld financial watch |
| Pubbl/distr/stampa | Atlanta, GA, : BioWorld Pub. Group |
| Descrizione fisica | 1 online resource |
| Disciplina | 660.6 |
| Soggetto topico |
Biotechnology industries - Economic aspects
Biotechnology industries - Finance |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Financial watch |
| Record Nr. | UNISA-996218448103316 |
| Atlanta, GA, : BioWorld Pub. Group | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
| Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi |
| Autore | Mellon Jim |
| Pubbl/distr/stampa | Chichester, West Sussex, U.K., : Wiley, 2012 |
| Descrizione fisica | 1 online resource (362 p.) |
| Disciplina | 338.4/76151 |
| Altri autori (Persone) | ChalabiAl |
| Soggetto topico |
Biotechnology industries - Finance
Pharmaceutical industry - Finance Biotechnology industries Pharmaceutical industry Investments |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-119-96937-9
1-280-67915-8 9786613656087 1-119-96936-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home? ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index |
| Record Nr. | UNINA-9910461624903321 |
Mellon Jim
|
||
| Chichester, West Sussex, U.K., : Wiley, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
| Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi |
| Autore | Mellon Jim |
| Pubbl/distr/stampa | Chichester, West Sussex, U.K., : Wiley, 2012 |
| Descrizione fisica | 1 online resource (362 p.) |
| Disciplina | 338.4/76151 |
| Altri autori (Persone) | ChalabiAl |
| Soggetto topico |
Biotechnology industries - Finance
Pharmaceutical industry - Finance Biotechnology industries Pharmaceutical industry Investments |
| ISBN |
1-119-96937-9
1-280-67915-8 9786613656087 1-119-96936-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home? ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index |
| Record Nr. | UNINA-9910790277003321 |
|
Mellon Jim
|
||
| Chichester, West Sussex, U.K., : Wiley, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cracking the code : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
| Cracking the code : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi |
| Autore | Mellon Jim |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex, U.K., : Wiley, 2012 |
| Descrizione fisica | 1 online resource (362 p.) |
| Disciplina | 338.4/76151 |
| Altri autori (Persone) | ChalabiAl |
| Soggetto topico |
Biotechnology industries - Finance
Pharmaceutical industry - Finance Biotechnology industries Pharmaceutical industry Investments |
| ISBN |
9786613656087
9781119969372 1119969379 9781280679155 1280679158 9781119969365 1119969360 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home? ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index |
| Record Nr. | UNINA-9911104863903321 |
|
Mellon Jim
|
||
| Chichester, West Sussex, U.K., : Wiley, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cracking the code : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
| Cracking the code : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi |
| Autore | Mellon Jim |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Wiley, 2012 |
| Descrizione fisica | 1 online resource (362 p.) |
| Disciplina | 338.4/76151 |
| Altri autori (Persone) | ChalabiAl |
| Soggetto topico |
Biotechnology industries - Finance
Pharmaceutical industry - Finance Biotechnology industries Pharmaceutical industry Investments |
| ISBN |
9786613656087
9781119969372 1119969379 9781280679155 1280679158 9781119969365 1119969360 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home? ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index |
| Record Nr. | UNINA-9911141957603321 |
| Mellon Jim | ||
| Wiley, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Valuation in life sciences [[electronic resource] ] : a practical guide / / Boris Bogdan, Ralph Villiger
| Valuation in life sciences [[electronic resource] ] : a practical guide / / Boris Bogdan, Ralph Villiger |
| Autore | Bogdan Boris |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Heidelberg, : Springer, 2008 |
| Descrizione fisica | 1 online resource (344 p.) |
| Disciplina |
332.63221
338.436151 |
| Altri autori (Persone) | VilligerRalph |
| Soggetto topico |
Valuation
Biotechnology industries - Finance |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-27620-0
9786611276201 3-540-78248-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Fundamentals in Life Sciences -- Basics of Valuation -- Valuation in Life Sciences -- Exercises -- Case Studies. |
| Record Nr. | UNINA-9910451144003321 |
|
Bogdan Boris
|
||
| Heidelberg, : Springer, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Valuation in life sciences [[electronic resource] ] : a practical guide / / Boris Bogdan, Ralph Villiger
| Valuation in life sciences [[electronic resource] ] : a practical guide / / Boris Bogdan, Ralph Villiger |
| Autore | Bogdan Boris |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Heidelberg, : Springer, 2008 |
| Descrizione fisica | 1 online resource (344 p.) |
| Disciplina |
332.63221
338.436151 |
| Altri autori (Persone) | VilligerRalph |
| Soggetto topico |
Valuation
Biotechnology industries - Finance |
| ISBN |
1-281-27620-0
9786611276201 3-540-78248-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Fundamentals in Life Sciences -- Basics of Valuation -- Valuation in Life Sciences -- Exercises -- Case Studies. |
| Record Nr. | UNINA-9910784993303321 |
|
Bogdan Boris
|
||
| Heidelberg, : Springer, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Valuation in life sciences : a practical guide / / Boris Bogdan, Ralph Villiger
| Valuation in life sciences : a practical guide / / Boris Bogdan, Ralph Villiger |
| Autore | Bogdan Boris |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Heidelberg, : Springer, 2008 |
| Descrizione fisica | 1 online resource (344 p.) |
| Disciplina |
332.63221
338.436151 |
| Altri autori (Persone) | VilligerRalph |
| Soggetto topico |
Valuation
Biotechnology industries - Finance |
| ISBN |
1-281-27620-0
9786611276201 3-540-78248-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Fundamentals in Life Sciences -- Basics of Valuation -- Valuation in Life Sciences -- Exercises -- Case Studies. |
| Record Nr. | UNINA-9911089194303321 |
|
Bogdan Boris
|
||
| Heidelberg, : Springer, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Valuation in life sciences : a practical guide / / Boris Bogdan, Ralph Villiger
| Valuation in life sciences : a practical guide / / Boris Bogdan, Ralph Villiger |
| Autore | Bogdan Boris |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Heidelberg, : Springer, 2008 |
| Descrizione fisica | 1 online resource (344 p.) |
| Disciplina |
332.63221
338.436151 |
| Altri autori (Persone) | VilligerRalph |
| Soggetto topico |
Valuation
Biotechnology industries - Finance |
| ISBN |
1-281-27620-0
9786611276201 3-540-78248-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Fundamentals in Life Sciences -- Basics of Valuation -- Valuation in Life Sciences -- Exercises -- Case Studies. |
| Record Nr. | UNINA-9911140011203321 |
| Bogdan Boris | ||
| Heidelberg, : Springer, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
